Respirology Search
Respirology Respirology
Most Read Articles
Dumping ACEis/ARBs over COVID-19 concern? Not so fast
Pearl Toh, 28 Apr 2020
There is currently no definite evidence showing that two classes of antihypertensive medications — ACE inhibitors and ARBs* — are linked to increased risk of COVID-19 infection, leading experts say. On the contrary, what is clear is that stopping these medications simply because of concern over their perceived theoretical risk can come at a price of adverse cardiovascular (CV) events.
How COVID-19 has changed our lives
Elvira Manzano, 01 Apr 2020
The coronavirus has been spreading at a frantic pace, isolating families and snuffing out lives. As hunger and emotional contagion grip the nations, the hope of a containment also dims. No one has seen this enemy coming – the world has underestimated COVID-19.

Podcast: Interview with Associate Prof Marysia Stella T. Recto: The role of bilastine in the treatment of allergic rhinitis and urticaria

01 Nov 2018
Podcast: Interview with Associate Prof Marysia Stella T. Recto: The role of bilastine in the treatment of allergic rhinitis  and urticaria
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Dumping ACEis/ARBs over COVID-19 concern? Not so fast
Pearl Toh, 28 Apr 2020
There is currently no definite evidence showing that two classes of antihypertensive medications — ACE inhibitors and ARBs* — are linked to increased risk of COVID-19 infection, leading experts say. On the contrary, what is clear is that stopping these medications simply because of concern over their perceived theoretical risk can come at a price of adverse cardiovascular (CV) events.
How COVID-19 has changed our lives
Elvira Manzano, 01 Apr 2020
The coronavirus has been spreading at a frantic pace, isolating families and snuffing out lives. As hunger and emotional contagion grip the nations, the hope of a containment also dims. No one has seen this enemy coming – the world has underestimated COVID-19.